ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 297,19
-0,05%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. SurModics Inc (SRDX)

  7. SurModics Inc (SRDX) Actualités

SRDX

SurModics (SRDX)

SurModics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SRDX
DateHeureSourceTitreSymboleSociété
30/05/202400h36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.NASDAQ:SRDXSurModics Inc
29/05/202414h04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SRDXSurModics Inc
29/05/202413h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRDXSurModics Inc
29/05/202413h00Business WireSurmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 MillionNASDAQ:SRDXSurModics Inc
24/05/202422h01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:SRDXSurModics Inc
01/05/202413h00Business WireSurmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
19/04/202413h00Business WireSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1NASDAQ:SRDXSurModics Inc
27/02/202414h00Business WireSurmodics to Participate in Upcoming Investor Conferences in March and AprilNASDAQ:SRDXSurModics Inc
12/02/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRDXSurModics Inc
09/02/202417h20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SRDXSurModics Inc
01/02/202414h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRDXSurModics Inc
01/02/202413h00Business WireSurmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
22/01/202413h30Business WireSurmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the KneeNASDAQ:SRDXSurModics Inc
16/01/202413h30Business WireSurmodics to Host Virtual Annual Meeting of ShareholdersNASDAQ:SRDXSurModics Inc
16/01/202413h30Business WireSurmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1NASDAQ:SRDXSurModics Inc
18/12/202322h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SRDXSurModics Inc
22/11/202316h22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SRDXSurModics Inc
16/11/202313h30Business WireSurmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposiumNASDAQ:SRDXSurModics Inc
16/11/202313h30Business WireSurmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH SymposiumNASDAQ:SRDXSurModics Inc
14/11/202322h05Business WireSurmodics to Participate in the Piper Sandler Healthcare Conference on November 28NASDAQ:SRDXSurModics Inc
08/11/202313h30Business WireSurmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
07/11/202313h30Business WireSurmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH SymposiumNASDAQ:SRDXSurModics Inc
07/11/202313h30Business WireSurmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15NASDAQ:SRDXSurModics Inc
31/10/202312h30Business WireSurmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device ApplicationsNASDAQ:SRDXSurModics Inc
10/10/202313h30Business WireSurmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8NASDAQ:SRDXSurModics Inc
09/08/202323h05Business WireSurmodics to Participate in Upcoming Investor Conferences in AugustNASDAQ:SRDXSurModics Inc
02/08/202313h31Business WireSurmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial GuidanceNASDAQ:SRDXSurModics Inc
12/07/202313h30Business WireSurmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2NASDAQ:SRDXSurModics Inc
20/06/202317h10Dow Jones NewsSurmodics Shares Up 8% on FDA Approval for SurVeil Drug-Coated BalloonNASDAQ:SRDXSurModics Inc
20/06/202313h23Dow Jones NewsSurmodics Gets FDA Approval for SurVeil Drug-Coated BalloonNASDAQ:SRDXSurModics Inc
 Showing the most relevant articles for your search:NASDAQ:SRDX

Dernières Valeurs Consultées

LSE
75MN
Hsbc Bk. 27
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés